Sphera Funds Management’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.58M Buy
128,515
+16,772
+15% +$336K 0.61% 55
2025
Q1
$2.2M Buy
+111,743
New +$2.2M 0.51% 60